Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line.
about
Structural characterization of the enzymes composing the arginine deiminase pathway in Mycoplasma penetransA large cell-adhesive scatter factor secreted by human gastric carcinoma cellsArgininosuccinate synthase: at the center of arginine metabolismArginine Metabolism in Bacterial Pathogenesis and Cancer TherapyChemoresistance to concanamycin A1 in human oral squamous cell carcinoma is attenuated by an HDAC inhibitor partly via suppression of Bcl-2 expressionInhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activityCultivation to improve in vivo solubility of overexpressed arginine deiminases in Escherichia coli and the enzyme characteristicsCharacterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoproteinArginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signalingA 48-kilodalton Mycoplasma fermentans membrane protein induces cytokine secretion by human monocytesBioengineered human arginase I with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts.Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth.Differential expression of argininosuccinate synthetase in serous and non-serous ovarian carcinomas.Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin's lymphoma cellsArginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma.Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures.Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cellsArginine dependence of tumor cells: targeting a chink in cancer's armor.Quantitative analysis of autophagy using advanced 3D fluorescence microscopy.Bioengineered arginase I increases caspase-3 expression of hepatocellular and pancreatic carcinoma cells despite induction of argininosuccinate synthetase-1.The relationship of arginine deprivation, argininosuccinate synthetase and cell death in melanoma.Anti-tumor activity of arginine deiminase from Mycoplasma argini and its growth-inhibitory mechanism.Chemical modification by polyethylene glycol of the anti-tumor enzyme arginine deiminase from Mycoplasma arginini.Deprivation of arginine by recombinant human arginase in prostate cancer cells.Induction of hyperammonia in irradiated hepatoma cells: a recapitulation and possible explanation of the phenomenon
P2860
Q21133926-D5BE5874-3A82-4D98-A0C4-481F4A0CA020Q24563665-341FBECC-0787-419D-B690-49BBE07EE222Q24620561-A9B48183-44E2-4C4F-B7E6-1AD36C28F0DCQ26765461-A9E5F718-E4F2-4F31-B11A-0C529EDFB1FCQ28535295-CF60D190-B497-47F6-9A1E-05CD1CCF0AFFQ33755853-D0E8BD8F-4238-44C1-844C-F12A6E267FBBQ33811623-68E78FCD-6389-452A-879D-4F2C2AF5D732Q34004121-96D39F48-8AFA-4042-BDFC-AB2E33313AA0Q34305783-081215DA-168F-4E20-80D3-E78759DF8119Q34536788-A1275E72-6255-4099-A974-A877172D000DQ35015474-7A6C08D9-6B8A-41DF-963E-3A569DAF8D6AQ35674875-F57CDEBC-A93F-4F48-9ECB-B3780F1FCB41Q36671753-2F79AAD6-4CD5-494B-98E7-B95045F3C29DQ36873800-4137A171-2767-49F8-B3AC-CB32ABD77DEEQ37068792-6F6DA394-A253-468C-BAF2-7C404679316DQ37299640-4A94415D-75E1-4A23-9635-30883BBC3B7BQ37748811-730E531C-FFEE-4845-A4D5-F91B0335AB63Q37820202-610A0EE7-EA45-4022-82E8-B579E2361EC1Q38310276-C41F8448-9EF0-400B-9889-EE66C551B4D7Q38326365-AD591DDB-1C4D-4630-8592-F49876BAB4DFQ38602768-72FDC8E7-40C0-4521-982C-3CA753401C1DQ38816145-15C73D11-8309-427B-A884-C1FD33B65B27Q39153310-7CB8585C-EF98-4ABB-B754-00CD5E6A2966Q39704277-83E2CAE1-FC34-4E9A-86FE-63F47C279034Q40188863-A110351F-1584-47B3-A985-37F54DF0EA83Q41304088-BA433BC1-E346-4ACE-8AE8-DD7BA617F0FBQ41516196-CA495148-C4CB-4B2D-AB04-7589F3D97CF5Q41850297-01CCA989-3D17-4676-92DB-1E88266201B9Q41879006-CBBC9EDA-A9D8-47FC-821D-E109BDCC0891
P2860
Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Potent growth inhibition of hu ...... Mycoplasma-infected cell line.
@en
type
label
Potent growth inhibition of hu ...... Mycoplasma-infected cell line.
@en
prefLabel
Potent growth inhibition of hu ...... Mycoplasma-infected cell line.
@en
P2093
P1433
P1476
Potent growth inhibition of hu ...... Mycoplasma-infected cell line.
@en
P2093
Miyazaki K
Yamashita J
P304
P407
P577
1990-08-01T00:00:00Z